Daily Stock Analysis: Organon & Co
Image Source: Unsplash
Organon & Co, bearing the ticker symbol OGN, has never been reviewed for any of my previous dog of the week portfolios. This is the very first mention of Organon for my Viking portfolio.
The company sells its products to drug wholesalers and retailers, hospitals, pharmacies, clinics, government agencies, health maintenance organizations, pharmacy benefit managers, and other institutions. ‘The company was incorporated in 2020 and is headquartered in Jersey City, New Jersey. |
Three key data points gauge Organon & Co or any dividend-paying firm. They are:
(1) Price
(2) Dividends
(3) Returns
Those three basic keys best tell whether any company has made, is making, and will make money.
OGN Price
Organon’s price per share was $20.87 at Friday’s market close. In the past year, its share price fell from $34.84 to its current $20.87 or about 56.25%
If Organon’s stock trades in the range of $18.00 to $28.00 this next year, its recent $20.87 share price might rise to $26.00 by next year. It could go down about the same amount.
My upside estimate of $5.13 a little under half the median of annual target increases estimated by nine analysts tracking the stock for brokers.
OGN Dividend
Organon’s recent $0.28 Q dividend yields 5.37% at Friday’s closing price.
OGN Returns
Adding the $1.12 projected annual dividend to my $5.13 estimated price upside reveals a $6.25 potential gross gain per share for the coming year.
At Friday’s $20.87 closing price, a little over $1000 would buy 48 shares.
A $10 broker fee (if charged), paid half at purchase and half at the sale, might cost us about $0.21 per share.
Subtract that maybe $0.21 brokerage cost from my estimated $6.25 gross gain estimate makes a net amount of $6.04 X 48 shares = $289.92 or a 29% net gain.
In the next year our $1K investment in shares of OGN could generate about $53.70 in dividends. Furthermore, a single share of Organon & Co at Friday’s $20.87 price is near 3 times less than the income estimated from $1000.00 invested.
So, by my dogcatcher ideal, this a time to consider Organon & Co based on its estimated dividends for 2023. The dividend from $1k invested is 2.6 times greater than OGN’s single-share price. Consider yourself alerted.
All of the estimates above are speculation based on the past history of investment in shares of Organon & Co. Only time and money invested in this stock will determine its future market value.
More By This Author:
Daily Stock Analysis: Sydbank A/S
Daily Stock Analysis: Carlyle Secured Lending
Daily Stock Analysis: Banco Santander Mexico
Disclaimer: This article is for informational and educational purposes only and should not be construed to constitute investment advice. Nothing contained herein shall constitute a ...
more
Comments
